Supreme Court rules generic drug design defect claims preempted by federal law
The US Supreme Court ruled 5-4 Monday in Mutual Pharmaceutical Company, Inc. v. Bartlett that generic drug design defect claims that turn on the adequacy of a drug's warnings are...